Abstract
(Anaesthesia. 2022;77:389–397) At the onset of the COVID-19 pandemic, world health authorities recommended neuraxial (NA) over general anesthesia (GA) for infected parturients. The intent for risk reduction was 2-fold: to reduce the risks accompanying GA in parturients with acute respiratory symptoms, and to minimize SARS-CoV-2 exposure to health care teams. Initial retrospective studies have shown paradoxically both increased and decreased use of NA versus GA in different studies, but many having low numbers of participants. With no large-scale multi-center study of trends of labor analgesia in COVID-19-positive parturients, there is a need for understanding of these interventions and associated outcomes that can influence future recommendations.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
